Curated News: Medical Meetings

• share
• favorite_border

Members of the public in counties with higher median household incomes are more likely to step into action to perform cardiopulmonary resuscitation, or CPR, when they witness someone have a cardiac arrest, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, which was presented today at the American Heart Association’s Resuscitation Science Symposium 2014.

• share
• favorite_border

Two or more serious hits to the head within days of each other can interfere with the brain’s ability to use sugar – its primary energy source – to repair cells damaged by the injuries, new research suggests.

• share
• favorite_border

A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine (PCV) administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain cancer, when compared to radiation therapy alone. The findings were part of the results of a Phase III clinical trial presented today at the Society for Neuro-Oncology’s 19th Annual Meeting in Miami by the study’s primary author Jan Buckner, M.D., deputy director, practice, at Mayo Clinic Cancer Center.

• share
• favorite_border

A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays and unnecessary side effects and expense. The research is among several Mayo Clinic studies presented at the American College of Rheumatology annual meeting in Boston.

• share
• favorite_border

A healthy diet may help protect the kidneys.

• share
• favorite_border

Carefully employing a TNF inhibitor dose-reduction strategy can be just as effective at safely treating RA patients as regular dosing methods, while also saving approximately $7,500 per patient annually.

• share
• favorite_border

Physically demanding jobs may increase the effects of inflammation on the progression of ankylosing spondylitis, possibly leading to increased bone formation in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Secukinumab, an anti-IL-17A monoclonal antibody biologic drug, showed promise as a treatment for patients with active ankylosing spondylitis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Rheumatologists at Geisinger Health System in Central Pennsylvania have developed a new model of rheumatoid arthritis patient care that is designed to improve quality while reducing costs, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Baseline levels of serum interferon in rheumatoid arthritis patients may help rheumatologists determine who will have a poor response to tumor necrosis factor-alpha inhibitor drugs, and one day help rheumatologists determine the best treatment options for individual RA patients.

• share
• favorite_border

Women with rheumatoid arthritis are at significantly higher risk of all-cause mortality, particularly respiratory causes, compared to women without the disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Not only does treatment with tumor necrosis factor (TNF) inhibitor biologic drugs not increase the risk of congestive heart failure in people with rheumatoid arthritis, but it may decrease the incidence of this serious cardiovascular disease in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Better clinical care and compliance might prevent most gout cases that require hospitalization, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Patients with rheumatic diseases who are treated with denosumab (Prolia®, Xgeva®) either alone, or in combination with either biologic or non-biologic disease-modifying antirheumatic drugs (DMARDs), do not appear to have a significant increased risk of infections.

• share
• favorite_border

Women using intrauterine devices (IUDs) may be at increased risk for producing autoantibodies related to the risk of developing rheumatoid arthritis (RA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Running as a habitual exercise at any stage in life not only does not increase a person’s risk of developing knee osteoarthritis and may even help protect a person from developing the painful disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Patients with end-stage lung disease due to systemic sclerosis should not simply be denied lung transplantation because of short- and long-term survival concerns due to extra-pulmonary factors, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

People with rheumatoid arthritis who are currently taking biologic drugs may be safely vaccinated for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.

• share
• favorite_border

Hydroxychloroquine (Plaquenil®), especially at the higher standard dose of 400 mg per day, independently decreases the risk of cardiovascular morbidity in people with rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.

• share
• favorite_border

Raman spectroscopy (RS) used at point of service could reduce the need for inpatient admission in patients with gout and pseudogout, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.